New breast imaging detects smallest tumors

Key points
- A technique called molecular breast imaging (MBI) is highly sensitive in detecting small lesions and can also spot tumors missed by mammography and ultrasound, researchers report.
- The results with the first 100 patients are "just staggering," Dr.
- The detection system involves injection of a standard short-lived isotope, which is taken up in breast tissue and preferentially by tumors.
- In their article, Rhodes' team describes the results when they tested the detection system with 40 patients.
A technique called molecular breast imaging (MBI) is highly sensitive in detecting small lesions and can also spot tumors missed by mammography and ultrasound, researchers report.
The results with the first 100 patients are "just staggering," Dr. Deborah J. Rhodes of the Mayo Clinic College of Medicine in Rochester, Minnesota, told AMN Health. "This technique really has many, many implications and many potential applications, but we certainly need further studies."
The detection system involves injection of a standard short-lived isotope, which is taken up in breast tissue and preferentially by tumors. The team built a gamma camera specifically designed to pick up the isotope signal and image the breast.
In their article, Rhodes' team describes the results when they tested the detection system with 40 patients. All of the women had small lesions that had been identified on a mammogram as "highly suggestive of malignancy," and were scheduled for needle biopsy.
That showed that 26 of the women had a total of 36 malignant lesions. When they were examined with the MBI system, it detected 33 of the lesions, as well as four lesions missed by both mammography and ultrasound.
The system the researchers developed not only identifies small lesions, they note; it also uses lighter compression than mammography, making it more tolerable to patients.
MBI may be particularly useful in patients with dense breasts, in whom standard mammography is much less sensitive, or women who are at greater risk of breast cancer, the researchers note.
The disadvantages of MBI, they continue, include the necessity of injecting radiotracers and the longer time required (40 to 50 minutes compared to 15 minutes) for the scan. However, Rhodes said her group is developing a new version of their MBI camera that will cut imaging time in half.
On the other hand, MBI has a number of advantages over MRI for detecting breast cancer, according to Rhodes. For instance, while MRI requires radiologists to sift through hundreds of images and interpretation is subjective, with MBI the picture is more clearcut. "There's either an abnormality or there's not," she said.
SOURCE: Mayo Clinic Proceedings, January 2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsRoche drugs, chemo destroy 46 percent of breast tumors
Combining experimental antibody drug pertuzumab with Herceptin, an antibody first approved in 1998, and chemotherapy shrank tumors in nearly half of newly diagnosed breast cancer patients treated in a clinical trial.…
13 December 2010
NewsBreast CT imaging system marches forward as pain-free tool to aid mammograms
While questions persist about the best ways to detect breast cancer early, a CT imaging system developed at the University of Rochester Medical Center and first unveiled five years ago is in a better position today to…
6 December 2010
NewsRemoving 2mm around breast cancer tumors prevents residual disease in 98 percent of patients
Removing an extra two millimetres around an area of invasive breast cancer is sufficient to minimise any residual disease in 98 per cent of patients, according to research published in the November issue of IJCP, the…

